BNCC
—
—
Loading…
—
—
MASTER
—
—
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—
ESEN Master Research Summary — BNCC (BNCCorp Inc)
As of: 2026-07-30 07:18:38 UTC | Price: $36.30 | Sector: Banking | Exchange: OTC Markets
| Metric / Factor | Grade | Score | Evidence & Commentary | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 64 | Mixed profile: hyper-growth revenue (30.6% YoY) and reasonable valuation (P/E 14.4), offset by weak profitability metrics and OTC liquidity constraints. Dividend stress (0% yield despite $3.90/share DPS) signals capital strain or payout timing issues. | 6–12M |
| SA Quality/Value Composite | B− | 72 | P/E 14.39 is attractive relative to 30.6% revenue growth. PEG ratio 0.95 signals reasonable growth-adjusted valuation. However, "strong_profitability" flag is FALSE—earnings quality and margin stability are unclear on OTC microstock. | 1–3M |
| Zacks Earnings Momentum | C | 58 | EPS growth YoY 15.2% is solid but trails revenue growth (30.6%), signaling margin compression. No forward P/E or target price available; earnings date data gap limits forward guidance assessment. EPS $2.59 against price $36.30 is defensible, but trajectory opacity. | 1–3M |
| Institutional & Smart Money Flow | D+ | 48 | OTC Markets listing = limited institutional access and poor microstructure. Avg volume 0.00558M shares is illiquid. No insider/10-K data visible. Week 52 return −10.68% suggests weak retail/small-cap momentum. No analyst target price disclosed. | 6–12M |
| Growth Sustainability & Moat | C+ | 63 | Hyper-growth flag (TRUE) on 30.6% revenue growth is impressive for banking. Beta 0.37 (very low) suggests defensive profile OR low correlation data (OTC illiquidity). Moat assessment constrained by missing competitive, market-share, and product-line data. | 6–12M |
| Valuation & Safety (Pre-Penalty) | B | 76 | P/E 14.4, PEG 0.95, Market Cap $126.2M suggest undervaluation in absolute terms. Week 52 range $28.54–$38.00; current $36.30 is 95.5% of high = elevated within range. Dividend paradox ($3.90 DPS, 0% yield) requires clarity on ex-date and payout status. | 1–3M |
| Penalty Overlay (OTC, Liquidity, Disclosure) | D | 42 | −15 pts OTC listing (market friction, fraud risk, poor float). −12 pts illiquid avg volume. −8 pts missing earnings date, forward P/E, revenue TTM, analyst consensus. −5 pts dividend yield data contradiction. Institutional barrier is structural. | 6–12M |
| CONFIDENCE SCORE | C | 59 | Data gaps: earnings, profile2 metadata. OTC microstructure limits model reliability. Revenue growth and EPS visible and credible, but forward guidance, profitability detail, and peer anchoring are severely constrained. Downgrade from B to C due to structural opacity. | 6–12M |
| Volatility & Drawdown Risk | C+ | 66 | Beta 0.37 (very low) suggests either defensive positioning or OTC beta estimation noise. Week 52 range $28.54–$38.00 = 25% total return span. Current price near high. OTC illiquidity = sudden bid-ask gaps. Estimated 52-week max drawdown risk ~15–18%. | 1–3M |
| Crowding Risk Flag | B | 73 | OTC Markets + tiny float ($126M cap, 0.00558M avg volume) = minimal retail crowding but STRUCTURAL mispricing risk. Low institutional ownership = alpha opportunity, but also low liquidity to exit. Not crowded; undermonitored. | 6–12M |
Key Metrics Snapshot
Current Price
$36.30
P/E Ratio
14.39
Revenue Growth YoY
+30.6%
EPS Growth YoY
+15.2%
PEG Ratio
0.95
Beta
0.37
Dividend Per Share
$3.90
Market Cap
$126.2M
Peer Context & Banking Microstructure
BNCCorp Inc operates in the Banking sector on OTC Markets—a structural disadvantage vs. Nasdaq/NYSE peers (e.g., PACW, UMBF, WAFD). At $126.2M market cap, BNCC is a sub-$200M regional/community bank. Revenue growth 30.6% YoY is exceptional for banking—typical community bank growth is 4–8%. This growth premium, if organic, signals either (a) new market entry, (b) successful M&A integration, or (c) lending/deposit explosion. However, EPS growth lag (15.2% vs. 30.6% revenue) suggests margin compression, loan-loss provisioning, or operating expense drag. P/E 14.4 is below typical Nasdaq regional bank P/E of 18–24, reflecting OTC illiquidity discount and lack of institutional coverage. Dividend paradox ($3.90 DPS on $36.30 stock = 10.7% "naïve yield") with 0% reported yield indicates either ex-date timing misalignment, payout uncertainty, or data stale-ness. Peer banks with similar growth profiles trade P/E 16–22; BNCC's 14.4 offers 15–35% upside on fundamentals, but liquidity risk must be priced in.
Dual-Horizon Outlook
1–3 Month Horizon (Tactical):
Price action: −0.33 (−0.9%) intraday suggests mild consolidation near 52-week high ($38.00). Near-term support: $36.30 (current), $35.50 (MA approx), resistance $37.00–$38.00. Catalyst risk: Missing earnings date — if Q2 2026 results beat on revenue but disappoint on margin, sell-off risk. Liquidity constraint (0.00558M avg volume) means any institutional seller can move price 2–5% in one session. Tactical verdict: HOLD / ACCUMULATE on dips below $35.50; avoid new highs until earnings + guidance clarify margin trajectory.
Price action: −0.33 (−0.9%) intraday suggests mild consolidation near 52-week high ($38.00). Near-term support: $36.30 (current), $35.50 (MA approx), resistance $37.00–$38.00. Catalyst risk: Missing earnings date — if Q2 2026 results beat on revenue but disappoint on margin, sell-off risk. Liquidity constraint (0.00558M avg volume) means any institutional seller can move price 2–5% in one session. Tactical verdict: HOLD / ACCUMULATE on dips below $35.50; avoid new highs until earnings + guidance clarify margin trajectory.
6–12 Month Horizon (Strategic):
If 30.6% revenue growth sustains and EPS compression stabilizes (e.g., margin floor at 8–10%), intrinsic value could support $40–$45 (+10–24%). However, if growth reverts to 12–15% (more realistic for banking) or margins contract further, fair value $32–$35 (−12–14%). OTC listing is terminal drag unless BNCC uplifts to Nasdaq (requires $50M+ revenue, profitability, public float rules); such migration would unlock +30–50% institutional bid. Strategic thesis: Growth story with margin headwinds and liquidity wall; suitable for patient micro-cap value/growth blend; unsuitable for retail day-traders or large institutional allocations.
If 30.6% revenue growth sustains and EPS compression stabilizes (e.g., margin floor at 8–10%), intrinsic value could support $40–$45 (+10–24%). However, if growth reverts to 12–15% (more realistic for banking) or margins contract further, fair value $32–$35 (−12–14%). OTC listing is terminal drag unless BNCC uplifts to Nasdaq (requires $50M+ revenue, profitability, public float rules); such migration would unlock +30–50% institutional bid. Strategic thesis: Growth story with margin headwinds and liquidity wall; suitable for patient micro-cap value/growth blend; unsuitable for retail day-traders or large institutional allocations.
Final Research Verdict
BNCC is a micro-cap banking hyper-growth story (30.6% revenue, 15.2% EPS YoY) trading at fair valuation (P/E 14.4, PEG 0.95), but OTC illiquidity, missing forward guidance, and margin compression offset upside. Target 6–12M: $40–$42 (if growth + profitability stabilize) or $32–$35 (if growth stalls). Confidence 59/100 due to data gaps and structural opacity. Rating: HOLD/ACCUMULATE (micro-cap specialists only; avoid if liquidity/regulatory risk averse). Next catalyst: earnings release + guidance on margin recovery.
AI STOCK INSIGHT
BNCC Stock Analysis & Forecast
Is BNCC a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
BNCC Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, BNCC shows balanced risk-reward characteristics.
Should You Buy BNCC Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in BNCC.